Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Positive Comparator, Randomized, Parallel Study of Efficacy, Safety, and Tolerability of AZD3480 (TC-1734-226) as Monotherapy in Patients With Mild to Moderate Dementia of the Alzheimer's Type

NCT01466088 is registered in ClinicalTrials.gov with Targacept Inc. as lead sponsor.

NCT NCT01466088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01466088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Positive Comparator, Randomized, Parallel Study of Efficacy, Safety, and Tolerability of AZD3480 (TC-1734-226) as Monotherapy in Patients With Mild to Moderate Dementia of the Alzheimer's Type
Lead sponsor
Targacept Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
May 31, 2014
Enrollment
386 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease